Y-Intercept (HK)’s Kyverna Therapeutics KYTX Stock Holding History

Y-Intercept (HK)’s Portfolio KYTX Stock Details KYTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$169K	Sell	24,811 -217,576	-90%	-$1.72M	﹤0.01%	1490
2026 Q2	$2.16M	Buy	242,387 +127,546	+111%	+$1.13M	0.04%	655
2026 Q1	$991K	Buy	+114,841	New	+$957K	0.02%	1033
2025 Q3	–	Sell	-42,025	Closed	-$129K	–	2129
2025 Q2	$129K	Buy	+42,025	New	+$104K	﹤0.01%	1513

Other funds holding KYTX

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Phoenix Wealth Advisors Chapel Hill, North Carolina $326M AUM 13.52% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Baldwin Wealth Partners Marion, Massachusetts $1.52B AUM 21.45% 1-Year Est. Return

Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return

Samalin Investment Counsel Chappaqua, New York $319M AUM 12.97% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Y-Intercept (HK)'s KYTX Position: Q3 2026 in Review

Y-Intercept (HK) reduced its Kyverna Therapeutics (KYTX) stake by 90% in Q3 2026, selling an estimated $1.72M and leaving 24,811 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Y-Intercept (HK) first reported a position in KYTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.16M in Q2 2026. 25 funds tracked by Wall St. Rank hold KYTX as of Q3 2026.

Y-Intercept (HK) held 24,811 shares of Kyverna Therapeutics worth $169K as of Q3 2026.
Y-Intercept (HK) sold 217,576 Kyverna Therapeutics shares in Q3 2026, an estimated $1.72M.
Kyverna Therapeutics made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1490 holding.
Y-Intercept (HK) first reported a position in Kyverna Therapeutics in Q2 2025 and has held it in 4 quarters since.
Y-Intercept (HK)'s Kyverna Therapeutics position peaked at $2.16M in Q2 2026.
25 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.